A while back I was interviewed by the NY Times about skincare products targeted to cancer patients. I'm glad to see the article presents these products lines for what they are . . . of little substance. There, of course, is no proof in the pudding as they say. I wrote a piece on Lindi Skincare line and their targeting of a vulnerable population.
This piece from the NY Times discusses the sad state and contradiction that is our health care system. Our cancer hospital gift shops may sells these product lines and many patrons might think that they work (why else would a hospital sell them) but in fact, neither are these products endorsed by the hospital, nor are they particularly effective at treating cancer patients' skincare needs.
Even though the oncologist physicians quoted in the interviews agree that these products aren't necessarily superior to any other skincare line, it would have been nice to get some quotes in by Dermatologists who could have much more easily dismissed the like of Lindi Skin and others.
The article also does a nice job at illustrating the rip-off prices of these products as well. Nice Job.